InvestorsHub Logo
Followers 37
Posts 4481
Boards Moderated 0
Alias Born 01/29/2010

Re: None

Sunday, 06/29/2014 12:02:36 PM

Sunday, June 29, 2014 12:02:36 PM

Post# of 97081
Next week marks one month since these words of encouragement were announced. We await with patience and anticipation...
"Robert Jagunich, Chairman of Decision Diagnostics, commented, "The very good news that we would like to share is that few Genstrip customers opted to return or exchange the earlier product version. We strongly believe that this suggests continued product acceptance and patient confidence. We also believe that it portends significant domestic growth and, also, rapid international expansion."

Mr. Berman concluded, "In the coming days we will be issuing an update detailing the plans and the successes of Mark Krakauer, who is spearheading our initiatives in the private label and value added channels. Additional information will also be circulated regarding our International growth; a highlighted area of company focus and concentration. International sales of diabetes supplies are fast outpacing domestic growth by almost 2:1 and have, as a result, consumed a significant increase in the company's attention and resources."